Simone Alves de Almeida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Simone Alves de Almeida has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Glaucia Rodrigues de Abreu
Department of Physiological Sciences, Health Sciences Center Federal University of Espírito Santo Vitória Brazil
3 shared publications - Antonio Augusto Peluso
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
2 shared publications - Patrick Wander Endlich
Mucuri School of Medicine, Graduate Program in Health Sciences Federal University of Jequitinhonha and Mucuri Valleys Teófilo Otoni Brazil
2 shared publications - Andrews Marques Do Nascimento
University Vila Velha
1 shared publication - Cristiane Lyrio da Silva
Faculdade Multivix Vila Velha
1 shared publication - Deiviany Santana Santos Lima
Mucuri School of Medicine, Graduate Program in Health Sciences Federal University of Jequitinhonha and Mucuri Valleys Teófilo Otoni Brazil
1 shared publication
Latest Publications
- Open Access
- 26 June 2026
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 30 (12) , e71262
Ellagic Acid Attenuates Oxidative Stress and Improves Cardiovascular Function Following Myocardial Infarction in Ovariectomized Rats
Oestrogen deficiency increases oxidative stress and reduces nitric oxide (NO) bioavailability, contributing to cardiac fibrosis following myocardial infarction (MI). This study investigated whether ellagic acid (EA), a natural antioxidant, attenuates post‐MI cardiac fibrosis in ovariectomized rats by reducing oxidative stress and pro‐inflammatory mediators. MI was induced by coronary artery ligation, and EA (30 mg/kg) was administered orally for 4 weeks. Hemodynamic parameters, collagen deposition, infarct size, matrix metalloproteinase‐8 (MMP‐8), NO, superoxide anion and inflammatory cytokines were assessed. MI resulted in ventricular dysfunction, increased collagen deposition and elevated levels of MMP‐8, interleukin‐6 (IL‐6) and superoxide anion. EA treatment improved hemodynamic function, reduced collagen deposition, decreased MMP‐8, IL‐6 and superoxide anion, and enhanced NO bioavailability. These findings demonstrate that EA mitigates cardiac fibrosis and ventricular dysfunction through antioxidant and anti‐inflammatory mechanisms, highlighting its potential as a cardioprotective compound in post‐MI conditions under oestrogen deficiency.
- 26 June 2026
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 30 (12) , e71262
Open AccessEllagic Acid Attenuates Oxidative Stress and Improves Cardiovascular Function Following Myocardial Infarction in Ovariectomized Rats
Oestrogen deficiency increases oxidative stress and reduces nitric oxide (NO) bioavailability, contributing to cardiac fibrosis following myocardial infarction (MI). This study investigated whether ellagic acid (EA), a natural antioxidant, attenuates post‐MI cardiac fibrosis in ovariectomized rats by reducing oxidative stress and pro‐inflammatory mediators. MI was induced by coronary artery ligation, and EA (30 mg/kg) was administered orally for 4 weeks. Hemodynamic parameters, collagen deposition, infarct size, matrix metalloproteinase‐8 (MMP‐8), NO, superoxide anion and inflammatory cytokines were assessed. MI resulted in ventricular dysfunction, increased collagen deposition and elevated levels of MMP‐8, interleukin‐6 (IL‐6) and superoxide anion. EA treatment improved hemodynamic function, reduced collagen deposition, decreased MMP‐8, IL‐6 and superoxide anion, and enhanced NO bioavailability. These findings demonstrate that EA mitigates cardiac fibrosis and ventricular dysfunction through antioxidant and anti‐inflammatory mechanisms, highlighting its potential as a cardioprotective compound in post‐MI conditions under oestrogen deficiency.
- Open Access
- 1 December 2025
- Published by Research, Society and Development in Research, Society and Development
- Vol. 14 (12)
Ovariectomized hypertensive rats submitted to exercise and estrogen therapy present improved levels of angiotensin receptors in the aorta
The renin-angiotensin system (RAS) and the antioxidant system play integral and interconnected roles in finely regulating cardiovascular function during exercise training and estrogen level alterations. This study aimed to investigate whether training modulates RAAS receptors and antioxidant proteins in a manner similar to 17β-estradiol (E2) therapy in the aorta of ovariectomized spontaneously hypertensive rats (SHR). Animals were divided into Sham (SH), Ovariectomized (OVX), OVX+ET (OE2), OVX+swimming (OSW) and OVX+ET+swimming (OE2+SW) groups. ET entailed the administration of 5 µg 17β-estradiol three times per week. Swimming was performed for one hour/day, five times per week. Two days after the last treatment and/or training session, systolic blood pressure was assessed. Protein content from isolated aorta was analyzed by western blot for the RAS receptors (angiotensin AT1-receptor - AT1R, angiotensin AT2-receptor - AT2R, and Mas receptor - Mas), endothelial nitric oxide synthase (eNOS), total and phosphorylated Protein Kinase B at Ser473 (p-AktSer473), Superoxide Dismutase 2 (SOD 2) and ß-actin. The results showed that AT1R was increased only in the OVX group, while angiotensin AT2R and Mas increased in both OSW and OE2+SW. In addition, ET therapy increased both eNOS and SOD 2 levels in SH, OE2 and OE2+SW. Interestingly, p-AktSer473 levels increased similarly in the same groups observed for eNOS. This study provided mechanistic evidence suggesting that both physical and hormonal interventions act via the protective RAS by stimulating the p-AktSer473-eNOS and SOD 2 pathways, which can be associated with vasodilation and potential antioxidant capacity in estrogen deficiency conditions.
- 1 December 2025
- Published by Research, Society and Development in Research, Society and Development
- Vol. 14 (12)
Open AccessOvariectomized hypertensive rats submitted to exercise and estrogen therapy present improved levels of angiotensin receptors in the aorta
The renin-angiotensin system (RAS) and the antioxidant system play integral and interconnected roles in finely regulating cardiovascular function during exercise training and estrogen level alterations. This study aimed to investigate whether training modulates RAAS receptors and antioxidant proteins in a manner similar to 17β-estradiol (E2) therapy in the aorta of ovariectomized spontaneously hypertensive rats (SHR). Animals were divided into Sham (SH), Ovariectomized (OVX), OVX+ET (OE2), OVX+swimming (OSW) and OVX+ET+swimming (OE2+SW) groups. ET entailed the administration of 5 µg 17β-estradiol three times per week. Swimming was performed for one hour/day, five times per week. Two days after the last treatment and/or training session, systolic blood pressure was assessed. Protein content from isolated aorta was analyzed by western blot for the RAS receptors (angiotensin AT1-receptor - AT1R, angiotensin AT2-receptor - AT2R, and Mas receptor - Mas), endothelial nitric oxide synthase (eNOS), total and phosphorylated Protein Kinase B at Ser473 (p-AktSer473), Superoxide Dismutase 2 (SOD 2) and ß-actin. The results showed that AT1R was increased only in the OVX group, while angiotensin AT2R and Mas increased in both OSW and OE2+SW. In addition, ET therapy increased both eNOS and SOD 2 levels in SH, OE2 and OE2+SW. Interestingly, p-AktSer473 levels increased similarly in the same groups observed for eNOS. This study provided mechanistic evidence suggesting that both physical and hormonal interventions act via the protective RAS by stimulating the p-AktSer473-eNOS and SOD 2 pathways, which can be associated with vasodilation and potential antioxidant capacity in estrogen deficiency conditions.
- Open Access
- 27 March 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (5)
Stanozolol induces ventricular dysfunction by decreasing phospholamban phosphorylation in heart tissue of LDLr-/- mice
Stanozolol is a steroid that causes lipid deposition in LDLr-/- mice, although the mechanism by which this dyslipidemia results in cardiac dysfunction is little understood. The aim of this study was to evaluate the effect of stanozolol on cardiac contractility and the participation of myocardial phospholamban (pPLB) phosphorylation in an atherosclerosis mouse model. LDL receptor knockout mice (LDLr-/-) were fed a standard chow diet and received weekly subcutaneous injections of either saline (control, C group) or 20 mg/kg stanozolol (S group). After 8 weeks, hemodynamic parameters were assessed in the left ventricle. The heart was collected, weighted for hypertrophy evaluation, and kept in formalin buffer for morphometric analysis (H&E) and collagen quantification (Picrossirius). Protein expression of PLB and its phosphorylated form (p-PLB) in the left ventricle was determined by western blot. We observed that stanozolol treatment favored cardiac hypertrophy and collagen deposition in heart tissue. Also, stanozolol induced left ventricle dysfunction, increasing PBL expression and decreasing the p-PLB/PLB ratio. Altogether, our data showed that stanozolol causes cardiac remodeling and ventricular dysfunction by decreasing PLB phosphorylation in the left ventricle of LDLr-/- mice.
- 27 March 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (5)
Open AccessStanozolol induces ventricular dysfunction by decreasing phospholamban phosphorylation in heart tissue of LDLr-/- mice
Stanozolol is a steroid that causes lipid deposition in LDLr-/- mice, although the mechanism by which this dyslipidemia results in cardiac dysfunction is little understood. The aim of this study was to evaluate the effect of stanozolol on cardiac contractility and the participation of myocardial phospholamban (pPLB) phosphorylation in an atherosclerosis mouse model. LDL receptor knockout mice (LDLr-/-) were fed a standard chow diet and received weekly subcutaneous injections of either saline (control, C group) or 20 mg/kg stanozolol (S group). After 8 weeks, hemodynamic parameters were assessed in the left ventricle. The heart was collected, weighted for hypertrophy evaluation, and kept in formalin buffer for morphometric analysis (H&E) and collagen quantification (Picrossirius). Protein expression of PLB and its phosphorylated form (p-PLB) in the left ventricle was determined by western blot. We observed that stanozolol treatment favored cardiac hypertrophy and collagen deposition in heart tissue. Also, stanozolol induced left ventricle dysfunction, increasing PBL expression and decreasing the p-PLB/PLB ratio. Altogether, our data showed that stanozolol causes cardiac remodeling and ventricular dysfunction by decreasing PLB phosphorylation in the left ventricle of LDLr-/- mice.
- Open Access
- 24 April 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (4) , e0215568
Exercise training improves vascular reactivity in ovariectomized rats subjected to myocardial infarction
The aim of this study was to evaluate the effects of exercise training (ET) on the aortic vascular reactivity of ovariectomized and infarcted rats. The animals were divided into 5 groups: Control, Ovariectomized + SHAM sedentary (OVX+SHAMSED), OVX+SHAM and ET (OVX+SHAMET), OVX + Myocardial Infarction sedentary (OVX+MISED), and OVX + MI and ET (OVX+MIET). ET protocol (60 minutes/day, 5x/week) in a motorized treadmill began 15 days after MI and lasted 8 weeks. The endothelium-dependent and endothelium-independent vascular reactivity were evaluated as well as the role of the reactive oxygen species (ROS). Superoxide and nitric oxide (NO) production were analyzed in situ using DHE and DAF-2 fluorescence, respectively. The expression of gp91phox and of the antioxidant enzymes were evaluated by western blotting in the thoracic aorta samples. MI promoted a significant increase in the contractile response and impaired endothelium-mediated relaxation. However, ET prevented the impairment in the vascular reactivity in MI animals. In addition, the protein expression of gp91phox and superoxide production increased and the NO production decreased in the OVX+MISED group but not in the OVX+MIET group. Therefore, ET improves vascular reactivity in MI ovariectomized rats by preventing the increase in the expression of gp91phox and the decrease in the antioxidant enzymes, resulting in a normal ROS and NO production. Thus, ET can be an effective therapeutic strategy for improving the MI-induced vascular alterations in estrogen deficiency condition.
- 24 April 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (4) , e0215568
Open AccessExercise training improves vascular reactivity in ovariectomized rats subjected to myocardial infarction
The aim of this study was to evaluate the effects of exercise training (ET) on the aortic vascular reactivity of ovariectomized and infarcted rats. The animals were divided into 5 groups: Control, Ovariectomized + SHAM sedentary (OVX+SHAMSED), OVX+SHAM and ET (OVX+SHAMET), OVX + Myocardial Infarction sedentary (OVX+MISED), and OVX + MI and ET (OVX+MIET). ET protocol (60 minutes/day, 5x/week) in a motorized treadmill began 15 days after MI and lasted 8 weeks. The endothelium-dependent and endothelium-independent vascular reactivity were evaluated as well as the role of the reactive oxygen species (ROS). Superoxide and nitric oxide (NO) production were analyzed in situ using DHE and DAF-2 fluorescence, respectively. The expression of gp91phox and of the antioxidant enzymes were evaluated by western blotting in the thoracic aorta samples. MI promoted a significant increase in the contractile response and impaired endothelium-mediated relaxation. However, ET prevented the impairment in the vascular reactivity in MI animals. In addition, the protein expression of gp91phox and superoxide production increased and the NO production decreased in the OVX+MISED group but not in the OVX+MIET group. Therefore, ET improves vascular reactivity in MI ovariectomized rats by preventing the increase in the expression of gp91phox and the decrease in the antioxidant enzymes, resulting in a normal ROS and NO production. Thus, ET can be an effective therapeutic strategy for improving the MI-induced vascular alterations in estrogen deficiency condition.